Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Viatris“
Suchtreffer
Begriffe & Kennungen
Ambrisentan Viatris (previously Ambrisentan Mylan)
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.1 Therapeutic indications · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 Contraindications · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · 3 Pregnancy (see section 4.6).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Baseline values of hepatic aminotransferases (aspartate aminotransferases (AST) and/or alanine aminotransferas
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Breast-feeding (see section 4.6).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Idiopathic pulmonary fibrosis (IPF), with or without secondary pulmonary hypertension (see section 5.1).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Severe hepatic impairment (with or without cirrhosis) (see section 4.2).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.3 · Women of child-bearing potential who are not using reliable contraception (see sections 4.4 and 4.6).
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · 6 Warfarin
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan does not inhibit or induce phase I or II drug metabolising enzymes at clinically relevant concentr
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan had no effects on the steady-state pharmacokinetics and anti-coagulant activity of warfarin in a h
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan is a substrate for Pgp-mediated efflux.
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Co-administration of ambrisentan with a phosphodiesterase inhibitor, either sildenafil or tadalafil (both subs
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Co-administration of rifampicin (an inhibitor of Organic Anion Transporting Polypeptide [OATP], a strong induc
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Cyclosporine A
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Effect of ambrisentan on xenobiotic transporters
Eintrag öffnen